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Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic disorder related to mutations in desmosomal proteins. There 
have been few histologic studies quantitating expression of desmosomal proteins in autopsy samples of ARVC.
Methods: We studied 29 patients (20 males, 9 females) dying suddenly with ARVC. Their age at death was 33 ± 4 and 32 ± 6 years, respectively. 
Control subject tissues were 15 men and 7 women, mean ages 36 ± 4 and 32 ± 6 years, respectively. Sections of heart were taken from short axis 
cuts from the right ventricle, left ventricular free wall, and ventricular septum. Areas free of fibrofatty change were assessed. Immunohistochemical 
stains against plakoglobin, plakophilin, and N-cadherin were applied and area expression analyzed by computerized morphometry correlated with a 
three-point scale of staining intensity.
Results: The mean area of plakoglobin expression showed no difference by gender (5.8% in men, 5.6% in women, p=0.9), cardiac site (left 
ventricle 6.0%, right ventricle 5.5%, and ventricular septum 5.7%, p=0.8), patient age (p=0.97), or presence of ARVC (6.0 ± 0.5% in controls, 5.7 ± 
0.3% in patients, p = 0.5). The mean area of plakophilin staining showed no difference by gender (5.4 ± .4% in men, 4.5 ± .3% in women, p=0.1), 
age (p=0.7), cardiac site (p=0.1), or presence of disease (5.4 ± .3% in controls, vs. 5.0 ± .2% in ARVC, p= 0.3). The mean area of N-cadherin 
staining showed no difference by gender (5.1 ± 0.5% in men vs. 5.1 ± 0.3% in women, p=.99), age (p=.08), or cardiac site (p = 0.7). The mean % 
staining by morphometry was 6.7 ± 0.4% in controls, vs. 4.5 ± 0.3% in ARVC, p=.0009. A positive predictive value of weak (1+ staining) for ARVC was 
76%, with a negative predictive value of 50% (88% sensitivity, and 30% specificity, respectively). By multivariate analysis, % N-cadherin staining was 
inversely proportional with the presence of ARVC, independent of other variables (p=.0001).
Conclusions: We conclude that immunohistochemical evaluation of desmoplakin and plakoglobin does not distinguish ARVC from controls. 
N-cadherin is significantly decreased, but as a qualitative measure is not a specific diagnostic tool.
